Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001

por Ning, Shoucheng, Sekar, Thillai Veerapazham, Scicinski, Jan, Oronsky, Bryan, Peehl, Donna M., Knox, Susan J., Paulmurugan, Ramasamy
Publicado 2015

Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model

por Malhotra, Meenakshi, Sekar, Thillai Veerapazham, Ananta, Jeyarama S., Devulapally, Rammohan, Afjei, Rayhaneh, Babikir, Husam A., Paulmurugan, Ramasamy, Massoud, Tarik F.
Publicado 2018